All-cause and cardiovascular mortality rates in the Casale Monferrato cohort of type 2 diabetes by metabolic syndrome at baseline examination (1991–1992)
| All-cause mortality | Cardiovascular mortality | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n deaths (rate/1,000 person-years) | HR* | HR† | HR‡ | n deaths (rate/1,000 person-years) | HR* | HR† | HR‡ | |||||||
| Metabolic syndrome | ||||||||||||||
| No | 165 (64.7) | 1.00 | 1.00 | 1.00 | 85 (33.4) | 1.00 | 1.00 | 1.00 | ||||||
| Yes | 520 (63.0) | 1.05 (0.88–1.25) | 1.04 (0.86–1.26) | 1.06 (0.86–1.30) | 256 (31.0) | 1.01 (0.78–1.28) | 1.04 (0.78–1.39) | 0.95 (0.71–1.28) | ||||||
| Number of components | ||||||||||||||
| 0 | 30 (58.7) | 1.00 | 1.00 | 1.00 | 11 (21.5) | 1.00 | 1.00 | 1.00 | ||||||
| 1 | 135 (66.2) | 1.19 (0.76–1.86) | 1.41 (0.86–2.31) | 1.37 (0.83–2.25) | 74 (36.3) | 2.39 (1.09–5.22) | 2.92 (1.16–7.33) | 2.80 (1.11–7.11) | ||||||
| 2 | 249 (68.3) | 1.17 (0.76–1.81) | 1.48 (0.90–2.33) | 1.36 (0.85–2.21) | 116 (31.8) | 1.83 (0.85–3.97) | 2.44 (0.99–6.06) | 2.21 (0.89–5.49) | ||||||
| >2 | 271 (58.8) | 1.07 (0.70–1.65) | 1.36 (0.85–2.19) | 1.25 (0.78–2.02) | 140 (30.4) | 2.10 (0.98–4.52) | 2.80 (1.14–6.92) | 2.46 (0.99–6.07) | ||||||
| P value for trend | 0.62 | 0.35 | 0.93 | 0.12 | 0.69 | 0.40 | ||||||||